Bio Protech Inc. (XKON:199290)
South Korea · Delayed Price · Currency is KRW 383.00
+4.00 (1.06%)
At close: Jan 30, 2026
Bio Protech Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|
Period Ending | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 |
Net Income | 552.54 | 143.58 | -1,419 | 1,120 | 734.16 |
Depreciation & Amortization | 1,184 | 1,040 | 1,404 | 769 | 625.49 |
Loss (Gain) From Sale of Assets | -0.09 | -70.05 | -1.12 | - | -0.36 |
Loss (Gain) From Sale of Investments | 90 | - | - | - | - |
Provision & Write-off of Bad Debts | 123.28 | 165.35 | 201.14 | -19.66 | 152.06 |
Other Operating Activities | 100.41 | 257.07 | 267.06 | 402.92 | 295.44 |
Change in Accounts Receivable | -3,039 | -1,278 | -97.58 | -513.42 | -1,106 |
Change in Inventory | -1,286 | -424.37 | 745.26 | -1,271 | -920.8 |
Change in Accounts Payable | 1,298 | -1,557 | -233 | 638.58 | 521.11 |
Change in Income Taxes | - | - | -79.33 | 79.33 | -35.29 |
Change in Other Net Operating Assets | 973.09 | 481.17 | -147.17 | 17.04 | -1,159 |
Operating Cash Flow | -3.89 | -1,242 | 639.87 | 1,223 | -893.42 |
Operating Cash Flow Growth | - | - | -47.67% | - | - |
Capital Expenditures | -784.31 | -702.05 | -1,801 | -3,318 | -852.58 |
Sale of Property, Plant & Equipment | 0.4 | 125 | 87.5 | - | 4.77 |
Sale (Purchase) of Intangibles | -425.91 | -909.91 | -866.67 | -276.71 | -921.85 |
Sale (Purchase) of Real Estate | - | - | -11.63 | - | - |
Investment in Securities | -811.46 | -304.65 | -661.58 | 206.85 | 312.97 |
Other Investing Activities | 4 | -9.9 | -23.28 | -18 | 5.95 |
Investing Cash Flow | -2,017 | -1,802 | -3,277 | -3,406 | -1,451 |
Short-Term Debt Issued | 9,278 | 8,821 | 5,683 | 1,591 | 3,726 |
Long-Term Debt Issued | 400 | 3,000 | - | 770 | - |
Total Debt Issued | 9,678 | 11,821 | 5,683 | 2,361 | 3,726 |
Short-Term Debt Repaid | -8,234 | -9,445 | -1,539 | - | -1,667 |
Long-Term Debt Repaid | -695 | -900 | -900 | -1,300 | -500 |
Total Debt Repaid | -8,929 | -10,345 | -2,439 | -1,300 | -2,167 |
Net Debt Issued (Repaid) | 749.68 | 1,477 | 3,244 | 1,061 | 1,559 |
Issuance of Common Stock | 330.45 | 1,991 | - | 4,497 | - |
Repurchase of Common Stock | - | - | -588.2 | -3,057 | - |
Other Financing Activities | - | 0 | -0 | 8.7 | 171.17 |
Financing Cash Flow | 1,080 | 3,468 | 2,656 | 2,509 | 1,731 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | 0 |
Net Cash Flow | -941.04 | 424.18 | 19.04 | 325.98 | -613.5 |
Free Cash Flow | -788.2 | -1,944 | -1,161 | -2,096 | -1,746 |
Free Cash Flow Margin | -3.83% | -10.45% | -6.43% | -11.64% | -10.35% |
Free Cash Flow Per Share | -283.88 | -541.56 | -748.44 | -557.49 | -611.21 |
Levered Free Cash Flow | -1,799 | -2,965 | -1,506 | -2,766 | -3,001 |
Unlevered Free Cash Flow | -1,264 | -2,421 | -1,050 | -2,354 | -2,669 |
Change in Working Capital | -2,054 | -2,778 | 188.18 | -1,050 | -2,700 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.